Saamya Biotech (India) Limited reported unaudited standalone earnings results for second quarter and six months ended September 30, 2014. For the quarter, the company reported loss from operations before other income, finance cost and exceptional items of INR 861,413 compared to INR 1,179,435 a year ago. Loss from ordinary activities before tax was INR 871,656 compared to INR 1,215,628 a year ago. Net loss for the period was INR 871,656 or INR 0.04 per basic and diluted share compared to INR 1,215,628 or INR 0.05 per basic and diluted share for the same period a year ago.

For the six months, the company reported loss from operations before other income, finance cost and exceptional items of INR 1,763,700 compared to INR 2,398,680 a year ago. Loss from ordinary activities before tax was INR 1,830,962 compared to INR 2,483,778 a year ago. Net loss for the period was INR 1,830,962 or INR 0.07 per basic and diluted share compared to INR 2,479,248 or INR 0.10 per basic and diluted share for the same period a year ago.